Principal Investigators
Ken R. Harewood, Ph.D.
Interim Director
Dr. Ken R. Harewood received his BA in Biology from New York University and his MS and Ph.D. in Biochemistry from City College of the City University of New York. After one year's postdoctoral research at the Lindsley F. Kimball Research Institute of the New York Blood Center where his research focused on gene expression regulation, Dr. Harewood spent 23 years as a member of the Central Research Division of Pfizer, Inc. where he applied molecular genetic strategies to study the role of oncogenes in the development of human cancer.
As Director of the Julius L. Chambers Biomedical/Biotechnical Research Institute (JLC-BBRI) and PI of North Carolina Central University's (NCCU's) EXPORT Center of Excellence, he leads a program that is conducting research that addresses minority health disparities.